{"resourceType": "Evidence", "id": "32144", "url": "https://fevir.net/resources/Evidence/32144", "meta": {"versionId": "20", "lastUpdated": "2023-12-06T17:46:14.323Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence", "http://hl7.org/fhir/uv/ebm/StructureDefinition/single-study-evidence"]}, "title": "ComparativeEvidence: Bariatric Surgery effect for ADA triple outcome at 5 years (Diabetes Surgery Study)", "status": "active", "copyright": "Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International", "relatedArtifact": [{"type": "derived-from", "label": "data source", "display": "Diabetes Surgery Study", "citation": "Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study [Journal Article]. Contributors: Sayeed Ikramuddin, Judith Korner, Wei-Jei Lee, Avis J Thomas, John E Connett, John P Bantle, Daniel B Leslie, Qi Wang, William B Inabnet, Robert W Jeffery, Keong Chong, Lee-Ming Chuang, Michael D Jensen, Adrian Vella, Leaque Ahmed, Kumar Belani, Charles J Billington. In: JAMA, PMID 29340678. Published January 16, 2018. Available at: https://pubmed.ncbi.nlm.nih.gov/29340678/.", "document": {"url": "https://fevir.net/resources/Citation/32147"}}, {"type": "cite-as", "citation": "ComparativeEvidence: Bariatric Surgery effect for ADA triple outcome at 5 years (Diabetes Surgery Study) [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32144. Revised 2022-05-28. Available at: https://fevir.net/resources/Evidence/32144. Computable resource at: https://fevir.net/resources/Evidence/32144."}], "description": "Of 120 participants who were initially randomized, 98 (82%) completed 5 years of follow-up. At 5 years, 13 participants (23%) in the gastric bypass group and 2 (4%) in the lifestyle-intensive medical management group had achieved the composite triple end point (difference, 19%; 95% CI, 4%-34%; P\u2009=\u2009.01).", "assertion": "In extended follow-up of obese adults with type 2 diabetes randomized to adding gastric bypass compared with lifestyle and intensive medical management alone, there remained a significantly better composite triple end point in the surgical group at 5 years. However, because the effect size diminished over 5 years, further follow-up is needed to understand the durability of the improvement.", "variableDefinition": [{"description": "Bariatric Surgery Trial Enrollment Group", "variableRole": "population", "observed": {"reference": "Group/32145", "type": "Group", "display": "120 participants who had a hemoglobin A1c (HbA1c) level of 8.0% or higher and a body mass index between 30.0 and 39.9 (enrolled between April 2008 and December 2011)"}}, {"description": "Group assignment", "variableRole": "exposure", "comparatorCategory": "Lifestyle-intensive medical management intervention based on the Diabetes Prevention Program and LookAHEAD trials for 2 years", "observed": {"reference": "EvidenceVariable/172481", "type": "EvidenceVariable", "display": "GroupAssignment: Roux-en-Y gastric bypass surgery vs. Lifestyle-intensive medical management intervention alone"}}, {"description": "American Diabetes Association composite triple end point for metabolic control at 5 years *NOTE: note.text is used artificially to support the EBMonFHIR Implementation Guide and the following content would more properly be found in a note.text element:* The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years", "variableRole": "outcome", "observed": {"reference": "EvidenceVariable/32143", "type": "EvidenceVariable", "display": "OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years"}}], "statistic": [{"description": "Of 120 participants who were initially randomized, 98 (82%) completed 5 years of follow-up. At 5 years, 13 participants (23%) in the gastric bypass group and 2 (4%) in the lifestyle-intensive medical management group had achieved the composite triple end point (difference, 19%; 95% CI, 4%-34%; P\u2009=\u2009.01).", "statisticType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/statistic-type", "version": "4.4.0", "code": "0000424", "display": "Risk Difference", "userSelected": true}]}, "quantity": {"value": 0.19}, "numberAffected": 15, "sampleSize": {"numberOfStudies": 1, "numberOfParticipants": 120, "knownDataCount": 98}, "attributeEstimate": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "C53324", "display": "Confidence interval"}]}, "level": 0.95, "range": {"low": {"value": 0.04}, "high": {"value": 0.34}}}]}], "date": "2022-05-28T11:56:53.907Z", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "32144", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "synthesisType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/synthesis-type", "code": "NotApplicable", "display": "not applicable"}]}, "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Brian S. Alper"}], "studyDesign": [{"coding": [{"system": "https://fevir.net/resources/CodeSystem/181513", "code": "SEVCO:01003", "display": "randomized assignment"}]}], "name": "ComparativeEvidence_Bariatric_Surgery_effect_for_ADA_triple_outcome_at_5_years_Diabetes_Surgery_Study"}